Abbvie Contract MFG

  Aseptic Fill Finish for Complex Drug Products Drugs conveyed through otic, ophthalmic, and parenteral routes have high risks of harm or infection. This is because they diverse many of the natural defenses in the body. To make sure patients are safe, the Food and Drug Administration demands that drug products conveyed through these paths be provided as sterile products.  This induction includes a lot of complex drug products, which include sterile injectables, ophthalmic suspension, aqueous-based aerosols (for inhalation), and lyophilized powders (injections) Our article talks about sterile lyophilization of drug products. To learn more about this, scroll down and keep reading.  Sterile Lyophilization of Duct Drug Products As big molecule formulations and drug products become popular, a large number of pharmaceutical formulations have challenges with solution stability and when this happens, there is impossibility of ready-to-use liquid dosage.  To fix this challeng...

Abbvie Drug Fill-Finish Products In the creation of an aseptic drug product, fill-finish is the last manufacturing step. Liquid filling in aseptic demands high technicians, ensuring that patients have safe and sterile products administered to them. At Abbvie, we offer GMP certified manufacturing capabilities. We process over a million vials annually with an automated filling line. Your drug product’s fill and finish procedures can be suited with customized packaging and labeling.  We have successfully advanced and distributed drug products for over 130 years, delivering products to more than 175 countries globally. There is no basis for the question as to whether or not we are excellent at what we do.  Terminal Sterilization  At Abbvie, our service package provides terminal sterilization. This includes a hundred percentage vial visual inspection with the use of labeling and packaging, polarized light, and batch certification.  We offer a very flexible service packag...

  Challenges Manufacturers Encounter During Aseptic Fill Finishing Aseptic fill finishing can be quite challenging, as asepsis techniques involve procedures that eliminate harmful spores, pathogens, parasites, viruses, and fungi. These procedures require careful planning from thoroughly trained personnel. The facilities and equipment used for this procedure are specialized and require expert care and handling. Any errors encountered during any of the drug development processes, storage, and transportation can affect how safe and efficacious the drugs are. Here are four of the most common challenges manufacturers face during fill finishing manufacturing . Four Challenges Encountered 1.Protein Structure and Stability When it comes to the manufacturing of protein-based drugs for large scale commercialization, many factors need to be considered. Different process parameters come into play when dealing with the production of drugs, from processing to storage and transportation. Each of ...

  Three Things Every Drug Manufacturer Should Have in Place Before Personally Handling their Fill Finish Fill finish is the last and arguably the most important stage in drug manufacturing. In layman's terms, fill finish refers to transferring a sterile drug from a sterile needle to a sterile container. This is a crucial part of the entire biopharmaceutical manufacturing process.  Fill finish is a common bottleneck in the manufacturing process; that's why manufacturers look to partner with a reliable third-party provider. However, the challenge is in choosing the right partner; we're here to make that decision a lot easier to make. Three Criteria That Should be in Place Before Any Fill Finish Process is Initiated Industry Standard Procedures In the pharmaceutical space, tried and true industry practices should always be the topmost priority; this should be your core message. Whether you’re choosing a third-party provider to contract your fill finish manufacturing or you ho...

  Fill and Finish Cell Therapy Abbvie Contract Manufacturing has the leading experts and a global network to scale-up and scale-out drug fill-finish , allogeneic and autologous therapies. Our cGMP manufacturing services deliver excellent operations, customer satisfaction, and future vision for your therapeutic product. Our state-of-the-art CGMP facilities are both FDA and EMA compliant, offering flexibility and confidence in manufacturing at a worldwide scale. Our expert development and manufacturing teams are sophisticated, and we partner with our gene therapy teams for viral vector production. This brings your cell therapy product from development to industrialization in a seamless process. Each facility has commercial manufacturing, clinical, and development operations offering full-service capabilities for our client needs. At Abbvie Contract Manufacturing, we excel in various projects, including suspension and adherent cells.  We have completed several projects as a strat...

  Abbvie Biologics' Drug Product Development Abbvie Biologics' drug development and manufacturing services leverage its proven expertise to provide biologics, biosimilars, and vaccines. Abbvie has extensive experience with drug fill finish process development for all its phases. Our scientists have experience in different sort of formulations and merchandise presentations for your drug product formulation. Whether your molecule needs vials (liquid or lyophilized) or syringes, Abbvie's high-speed filling lines offer the absolute best degree of aseptic processing. They are integrated with secondary packaging to supply your clinical or commercial product to patients reliably. Process Development From cell culture through recovery and purification, our scientists develop processes that ensure consistent CGMP manufacturing performance and a reliable product supply. The use of identical bioreactors helps a smooth transition from non-GMP to GMP manufacturing. Comprehensive, integ...

  Why Aseptic Fill Finish is Essential to the Pharmaceutical Industry An aseptic fill finish , also known as sterile filling of drugs, is the last and one of the most challenging stages in the drug creation processes. This process is so complex because it requires careful planning, thoroughly trained workers, and specialized facilities/ equipment to pull it off. It also requires close coordination and complex interactions between the persons operating the systems, sterilized products, clean room, and sterilized filling equipment. This process of fill finish manufacturing is a process that relies significantly on a perfect technique, and slight errors can have a significant impact on the end-users. Considering that these sterile drugs are to be used on already compromised patients, it is important that they relieve and not further complicate the situation. Many complex biochemical, pharmaceutical, and biotechnology drugs products wouldn't be able to undergo terminal sterilization ri...